Decoding the Evidence: A Synopsis of Indications and Evidence for Catheter Ablation in Atrial Fibrillation (Review)

Overview

Journal Med Int (Lond)

Publisher Spandidos Publications

Specialty General Medicine

Date 2024 Nov 20

PMID 39563946

Authors

Omar Obeidat

Mohamed F Ismail

Saeed Abughazaleh

Hashim Al-Ani

Mohammad Tarawneh

Laith Alhuneafat

Ali Obeidat

Abedallah Obeidat

Qusai Alqudah

Mohd Alamin Daise

Hamza Alzghoul

Mohammad Al-Hammouri

Ward Althunibat

Ann Tong

Mazahir Alimohamed

Affiliations

Soon will be listed here.

Abstract

The present study reviews the role of catheter ablation (CA) in the management of atrial fibrillation (AF), a widespread arrhythmia associated with increased morbidity and mortality. The present review explores current indications and recent evidence supporting CA, assessing patient outcomes and identifying common complications associated with the procedure. Emphasis is placed on optimizing risk factors prior to ablation, including weight control and hypertension management, as these measures can significantly enhance post-procedural outcomes. The present review also discusses the use of antiarrhythmic and anticoagulant therapies following CA to minimize recurrence and reduce stroke risk. Additionally, the cost-effectiveness of CA is discussed, comparing its long-term economic impact with that of medical therapy alone. The present comprehensive review provides insight into best practices for AF management, supporting CA as a promising approach when integrated with targeted lifestyle modifications and pharmacological support for improved, patient-centered outcomes.

References

Eckard N, Davidson T, Walfridsson H, Levin L . Cost-Effectiveness Of Catheter Ablation Treatment For Patients With Symptomatic Atrial Fibrillation. J Atr Fibrillation. 2017; 2(2):195. PMC: 5398774. DOI: 10.4022/jafib.195. View

Deedwania P, Lardizabal J . Atrial fibrillation in heart failure: a comprehensive review. Am J Med. 2010; 123(3):198-204. DOI: 10.1016/j.amjmed.2009.06.033. View

Barra S, Narayanan K, Boveda S, Primo J, Goncalves H, Baran J . Atrial Fibrillation Ablation and Reduction of Stroke Events: Understanding the Paradoxical Lack of Evidence. Stroke. 2019; 50(10):2970-2976. DOI: 10.1161/STROKEAHA.119.026890. View

Sharma P, Padala S, Gunda S, Koneru J, Ellenbogen K . Vascular Complications During Catheter Ablation of Cardiac Arrhythmias: A Comparison Between Vascular Ultrasound Guided Access and Conventional Vascular Access. J Cardiovasc Electrophysiol. 2016; 27(10):1160-1166. DOI: 10.1111/jce.13042. View

Steinbeck G, Sinner M, Lutz M, Muller-Nurasyid M, Kaab S, Reinecke H . Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. Eur Heart J. 2018; 39(45):4020-4029. PMC: 6269631. DOI: 10.1093/eurheartj/ehy452. View

Freedman B, Martinez C, Katholing A, Rietbrock S . Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation. JAMA Cardiol. 2016; 1(3):366-8. DOI: 10.1001/jamacardio.2016.0393. View

Santhanakrishnan R, Wang N, Larson M, Magnani J, McManus D, Lubitz S . Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation. 2016; 133(5):484-92. PMC: 4738087. DOI: 10.1161/CIRCULATIONAHA.115.018614. View

Shah A, Mittal S, Sichrovsky T, Cotiga D, Arshad A, Maleki K . Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol. 2008; 19(7):661-7. DOI: 10.1111/j.1540-8167.2008.01101.x. View

McKenna C, Palmer S, Rodgers M, Chambers D, Hawkins N, Golder S . Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart. 2008; 95(7):542-9. DOI: 10.1136/hrt.2008.147165. View

10.

Andrade J . Ablation as First-line Therapy for Atrial Fibrillation. Eur Cardiol. 2023; 18:e46. PMC: 10398511. DOI: 10.15420/ecr.2023.04. View

11.

Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu M, Rasmussen L . Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2014; 128(5):509-18.e2. DOI: 10.1016/j.amjmed.2014.11.026. View

12.

Zafrir B, Lund L, Laroche C, Ruschitzka F, Crespo-Leiro M, Coats A . Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J. 2018; 39(48):4277-4284. DOI: 10.1093/eurheartj/ehy626. View

13.

Maesen B, van der Heijden C, Bidar E, Vos R, Athanasiou T, Maessen J . Patient-reported quality of life after stand-alone and concomitant arrhythmia surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2021; 34(3):339-348. PMC: 8860412. DOI: 10.1093/icvts/ivab282. View

14.

Raymond R, Lee A, Messineo F, Manning W, Silverman D . Cardiac performance early after cardioversion from atrial fibrillation. Am Heart J. 1998; 136(3):435-42. DOI: 10.1016/s0002-8703(98)70217-0. View

15.

Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700. DOI: 10.1001/jama.2014.467. View

16.

Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R . Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008; 118(24):2498-505. DOI: 10.1161/CIRCULATIONAHA.108.772582. View

17.

Inada K, Yamane T, Tokutake K, Yokoyama K, Mishima T, Hioki M . The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace. 2013; 16(2):208-13. DOI: 10.1093/europace/eut159. View

18.

Takigawa M, Takahashi A, Kuwahara T, Takahashi Y, Okubo K, Nakashima E . Impact of Alcohol Consumption on the Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation. J Am Heart Assoc. 2016; 5(12). PMC: 5210418. DOI: 10.1161/JAHA.116.004149. View

19.

Turagam M, Musikantow D, Whang W, Koruth J, Miller M, Langan M . Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials. JAMA Cardiol. 2021; 6(6):697-705. PMC: 8082432. DOI: 10.1001/jamacardio.2021.0852. View

20.

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg M, Green M . Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med. 2000; 342(13):913-20. DOI: 10.1056/NEJM200003303421302. View